Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

166 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

NCT01174108

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +11 more
Locations
  • University of Maryland, Baltimore (UMB) Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

NCT05744921

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Hospital Pablo Tobon Uribe Medellín, Antioquia, Colombia
  • Semmelweis University/Semmelweis Egyetem Budapest, Hungary
  • Amrita Institute of Medical Sciences (AIMS) and Research Centre Aims Kochi, Kerala, India
View all 47 locations
View Trial Details
Recruiting

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

NCT06934967

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • St Jude Childrens Research Hospital Memphis, Tennessee, United States
  • Novartis Investigative Site Brasília, Federal District, Brazil
  • Novartis Investigative Site Natal, Rio Grande do Norte, Brazil
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

NCT07154745

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Hospital das Clinicas da FMRP USP Ribeirão Preto, São Paulo, Brazil
  • Faculdade de Medicina do ABC Santo André, São Paulo, Brazil
  • CISSS-CA Lévis, Quebec, Canada
  • Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli Rome, Lazio, Italy
View all 20 locations
View Trial Details
Recruiting

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

NCT07187401

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +6 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • St. Vincent Hospital - The Catholic University of Korea Suwon, Gyeonggi-do, South Korea
  • The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Recruiting

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07229235

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Alessandria, AL, Italy
  • Novartis Investigative Site Avellino, AV, Italy
  • Novartis Investigative Site Brescia, BS, Italy
  • Novartis Investigative Site Florence, FI, Italy
View Trial Details

Related conditions